HUNT VALLEY, Md., Jan. 6, 2015 /PRNewswire/ -- Pharmaceutics International, Inc. (Pii), a Contract Development Manufacturing Organization (CDMO) based in Hunt Valley, MD, announced today the completion of the expansion of their manufacturing facility. This expansion, together with the purchase of new 300L fluid beds for solvent coating, is in preparation for future commercial approvals. Pii has over 40 products pending approval with the FDA. In addition, Pii's UK subsidiary, Pharmaterials, has added 11 new manufacturing suites for the European market. Steve King, Pii's Senior Vice President, noted "The increased capacity and capabilities in the USA and UK will support Pii's future growth with further expansions planned in 2015 and beyond."
About Pharmaceutics International, Inc.
Pii is a privately held CDMO providing dosage form development and GMP manufacturing services to the global pharmaceutical industry. Headquartered in Hunt Valley, Maryland USA with European facilities in the UK, services include preformulation testing, formulation development, clinical and commercial GMP manufacturing of solid, parenteral, inhalation, semi-solid and liquid dosage forms, clinical packaging and labeling, clinical trial kit building and distribution, analytical and QP services. Pii's facilities include manufacturing and containment suites, automated packaging lines and a wide selection of equipment. For more information, please visit www.pharm-int.com.
Audrey Sieling, Business Development Associate
Pharmaceutics International, Inc.
10819 Gilroy Road
Hunt Valley, MD 21031
Phone: (410) 584-0001
SOURCE Pharmaceutics International, Inc. (Pii)